Showing results (601-610 of 652) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|March 5, 2023
The relationship of stress coping styles on substance use, depressive symptoms, and personality traits of nurses in higher education institutionKeita Tokumitsu, Norio Sugawara, Hiroaki Okayasu, et al.
Neuropsychopharmacology Reports|August 1, 2022
Topiramate and other kainate receptor antagonists for depression: A systematic review of randomized controlled trialsAhmad Shamabadi
Neuropsychopharmacology Reports|May 7, 2021
Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspectiveSusmita Pandey, Ingeborg Bolstad, Lars Lien, et al.
Neuropsychopharmacology Reports|November 24, 2025
Vitamin D3 Supplementation Modulates Inflammatory Protein CHI3L1/YKL-40 and Oxidative Stress Status in Multiple SclerosisSevda Asadpour, Mehrdokht Mazdeh, Jamshid Karimi, et al.
Neuropsychopharmacology Reports|November 20, 2025
Gray Matter Alterations and Symptom Severity in Forensic Psychiatric Patients: An Exploratory VBM StudyGaia Cartocci, Maddalena Boccia, Pieritalo Maria Pompili, et al.
Neuropsychopharmacology Reports|November 12, 2025
Adrenal Insufficiency-Induced Delirium Following Gastrectomy in a Patient With Gastric Cancer Treated With Nivolumab, Immune Checkpoint Inhibitors: A Case ReportKazuki Yamada, Taro Sasaki, Tamaki Owada, et al.
Neuropsychopharmacology Reports|December 22, 2025
Effect of the rs7858836 Single-Nucleotide Polymorphisms of the ASTN2 Gene on Pain-Related Phenotypes in Japanese Women Who Underwent Laparoscopic Gynecologic SurgeryRie Inoue, Daisuke Nishizawa, Shoko Okahara, et al.
Neuropsychopharmacology Reports|June 26, 2025
Clinical Characteristics of Patients With Enlarged Ventricles and Cognitive Impairment (EVCI): Case SeriesYuka Yasuda, Satsuki Ito, Junya Matsumoto, et al.
Neuropsychopharmacology Reports|July 1, 2025
Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in JapanYuji Masataka, Munenori Katayama, Futaba Umemura, et al.
Neuropsychopharmacology Reports|September 25, 2025
Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With SchizophreniaAquib Butt, Soban Sadiq
Pageof 66